Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trialLoretta Fiorillo, Lisa M. Arkin, R. de Lucas et al.|Journal of the American Academy of Dermatology|2024Cited by 28